Studies including ours have shown that multiple tumor lines including melanoma, lung, lymphoma, pancreatic, and nasopharyngeal carcinomas generate oxidized PAF agonists in response to chemotherapeutic agents or radiation therapy, with increased levels were detected in PAFR-expressing tumor cells (41, 42, 52, 64). The gene discussed is PCLAF; the disease is neoplasm.